Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia
- PMID: 38970273
- DOI: 10.1002/ajh.27429
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia
Abstract
Multivariable analysis for overall survival and relapse-free survival demonstrating lack of significant for D14 BM status.
© 2024 Wiley Periodicals LLC.
Similar articles
-
A new model to predict remission status in AML patients based on day 14 bone marrow biopsy.Leuk Res. 2016 Jul;46:69-73. doi: 10.1016/j.leukres.2016.04.013. Epub 2016 Apr 20. Leuk Res. 2016. PMID: 27132034
-
Prognostic and Therapeutic Value of Day 14 Bone Marrow Aspiration in Adult Acute Myeloid Leukemia Patients.Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e406-e413. doi: 10.1016/j.clml.2019.03.024. Epub 2019 Apr 1. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31031147
-
Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort.Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e427-e436. doi: 10.1016/j.clml.2020.02.012. Epub 2020 Feb 26. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32201130
-
Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases.Asian Pac J Cancer Prev. 2018 Feb 26;19(2):421-425. doi: 10.22034/APJCP.2018.19.2.421. Asian Pac J Cancer Prev. 2018. PMID: 29479992 Free PMC article.
-
Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.Cancer. 2016 Dec 15;122(24):3812-3820. doi: 10.1002/cncr.30262. Epub 2016 Aug 10. Cancer. 2016. PMID: 27508525 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical